Skip to main content
CYRX
NASDAQ Life Sciences

Cryoport Projects 2026 Revenue Between $192M and $196M

feedReported by Dow Jones Newswires
Sentiment info
Neutral
Importance info
8
Price
$10.62
Mkt Cap
$512.521M
52W Low
$5.31
52W High
$11.45
Market data snapshot near publication time

summarizeSummary

Cryoport, Inc. has issued its revenue guidance for fiscal year 2026, forecasting sales to be in the range of $192 million to $196 million. This guidance provides a crucial forward-looking metric for investors and analysts to assess the company's expected top-line performance and growth prospects. This is new, material information that directly impacts financial models and investment theses, as it was not previously disclosed in the recent SEC filings or news within the provided timeline. Professional traders would need to incorporate this guidance immediately to update their valuations and adjust their positions.

At the time of this announcement, CYRX was trading at $10.62 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $512.5M. The 52-week trading range was $5.31 to $11.45. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.


show_chartPrice Chart

Share this article

Copied!

feed CYRX - Latest Insights

CYRX
May 05, 2026, 2:36 PM EDT
Filing Type: 10-Q
Importance Score:
8
CYRX
May 04, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
8
CYRX
May 04, 2026, 4:22 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
CYRX
Apr 22, 2026, 4:31 PM EDT
Filing Type: DEFA14A
Importance Score:
7
CYRX
Apr 22, 2026, 4:30 PM EDT
Filing Type: DEF 14A
Importance Score:
7
CYRX
Mar 05, 2026, 4:53 PM EST
Filing Type: 10-K
Importance Score:
9
CYRX
Mar 03, 2026, 5:10 PM EST
Filing Type: 8-K
Importance Score:
8
CYRX
Mar 03, 2026, 4:36 PM EST
Source: Reuters
Importance Score:
8
CYRX
Mar 03, 2026, 4:09 PM EST
Source: Dow Jones Newswires
Importance Score:
8